Share |
Press Releases 2014
December 31, 2014 at 4:39 pm

Verisante Technology, Inc. Announces Non-Brokered Private Placement and Year End Operational Update


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, today announced it has closed a non-brokered private placement of 3,888,889 common shares at a price of $0.09 per share for gross proceeds of $350,000. The private placement...

Full story

November 10, 2014 at 2:00 pm

Verisante Technology, Inc. to Present at 2nd Emerging Medical Technologies (EMT) Summit


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, today announced that Thomas Braun, President & CEO, will present at the upcoming Emerging Medical Technologies (EMT) Summit  in San Francisco on November 11, 2014 at the Sofitel Hotel...

Full story

October 15, 2014 at 4:22 pm

Verisante Technology, Inc. Announces Non Brokered Private Placement


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today it has closed a non-brokered private placement of 2,500,000 common shares at a price of $0.14 per share for gross proceeds of $350,000. The private placement comes...

Full story

October 1, 2014 at 3:00 pm

Verisante Technology, Inc. Announces Submission to the FDA for Aura, a Skin Cancer Detection Device


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today it has initiated communications with the Food and Drug Administration (“FDA”) in the United States for the approval of Aura™, a device for the detection of skin...

Full story

September 30, 2014 at 3:00 pm

Verisante Technology, Inc. Announces Re-negotiated Letter of Intent for equity stake in Chinese Company


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today it has renegotiated a Letter of Intent between the Company and strategic partner (the “Partner”) in the People’s Republic of China, which terms were previously announced on...

Full story

September 25, 2014 at 3:00 pm

Verisante Technology, Inc. to Present at 2nd Global Life Sciences Conference in Warsaw and Announces change in Board


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, today announced that Thomas Braun, President & CEO will present at the upcoming 2nd Global Life Sciences Conference in Warsaw on October 2, 2014 at the trading floor of...

Full story

July 29, 2014 at 4:00 pm

Verisante Technology, Inc. Welcomes Dr. Kenneth Beer and Dr. Philip Werschler onto Clinical Advisory Board


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc . (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, is pleased to welcome Dr. Kenneth Beer, MD, PA and Dr. Wm. Philip Werschler, MD, FAAD, FAACS, onto the Company’s Clinical Advisory Board. “Both Dr. Beer and...

Full story

June 25, 2014 at 2:30 pm

Verisante Technology, Inc. Announces Non Brokered Private Placement and LOI for Exclusive Sales and Marketing Rights in China


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today it has closed a non-brokered private placement of 2,000,000 common shares at a price of $0.15 per share for gross proceeds of $300,000. The private placement...

Full story

June 10, 2014 at 1:30 pm

Verisante Technology, Inc. Partners with the BC Cancer Foundation to Showcase Aura™ for Skin Cancer Detection


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company is partnering with the BC Cancer Foundation to showcase Verisante Aura™, a device for the detection of skin cancer. “We are very appreciative...

Full story

June 3, 2014 at 1:45 pm

Edison Research Initiates Coverage on Verisante Technology, Inc.


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that Edison Research, an investment research firm, has initiated coverage on the Company. The report on Verisante is now available for download from Edison’s website at:...

Full story

June 2, 2014 at 1:30 pm

Verisante Technology, Inc. Announces 2014 First Quarter Results and Provides Operational Update


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has released its financial results for the first quarter ended March 31, 2014 . Highlights of the quarter include Launched...

Full story

May 29, 2014 at 2:30 pm

Verisante Technology Inc. Announces Preliminary License Agreement with Astoria Capital for Cancer Detection Technology


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced  today it has signed a letter of intent, subject to a final definitive agreement, with Astoria Capital SA (WAR: ACL)  to sub-license and, in turn, finance the development...

Full story

May 20, 2014 at 3:51 pm

Verisante Technology, Inc. Receives the 2014 North American Technology Innovation Leadership of the Year Award


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has been honoured by Frost & Sullivan with the 2014 North American Technology Innovation Leadership of the Year Award for In Vivo Cancer Detection...

Full story

May 13, 2014 at 1:30 pm

Verisante Technology, Inc. Announces Milestone Completion of Core™ Commercial Prototype for the Detection of Lung Cancer


COMPLETES RECERTIFICATION OF ISO CERTIFICATE OF QUALITY MANAGEMENT SYSTEM FOR MEDICAL DEVICE MANUFACTURING VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has completed the development of the Core™ Series commercial prototype...

Full story

May 2, 2014 at 1:00 pm

Verisante Technology, Inc. Recognizes May as National Skin Cancer Awareness Month


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, recognizes May as skin cancer awareness month and reminds the public to wear sunscreen and get screened for skin cancer. Skin cancer is the most common form of...

Full story

May 1, 2014 at 2:50 am

Verisante Technology, Inc. Announces 2013 Year End Results
and Strategy for Direct Distribution


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has released its financial results for the year ended December 31, 2013. Highlights of the year include: • First revenues from...

Full story

March 18, 2014 at 5:00 pm

Verisante Completes Private Placement


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), announced today that it has closed a non-brokered private placement of 2,827,000 units (“Units”) at a price of $0.17 per Unit for gross proceeds of $480,590.  Each Unit consists of one common share of the...

Full story

March 12, 2014 at 2:00 pm

Verisante Technology, Inc. Expands Intellectual Property Portfolio


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Chinese Patent Office has issued a decision to grant Patent Application No. 2006800074 entitled “Methods and Apparatus for Measuring Cancerous Changes from Reflectance Spectral Measurements...

Full story

February 26, 2014 at 2:00 pm

Verisante Technology, Inc. Grows Sales and Marketing Team


Announces Hiring of Global Sales Director and Sales Representative for Canada VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has hired Jason Mangler as Director of Sales to guide the Company’s...

Full story

February 4, 2014 at 1:30 pm

Verisante Technology, Inc. Launches New Product at SPIE Photonics West 2014 in San Francisco, CA


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company is launching a new product at the SPIE Photonics West 2014 industry exhibit in San Francisco, California from February 4-6, 2014. Photonics West is...

Full story

  Back to top